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A 77-year-old man was referred to our department for surgical treatment of a right ureteral stone
identiﬁed on computed tomography (CT) during intensive examination for spondylolisthesis of L4-L5. At
the initial visit, performance status was 4, and renal dysfunction was identiﬁed (Cr 1.3 mg/dl). Corrected
calcium level was 11.8 mg/dl, and intact parathyroid hormone level was 555 pg/ml. A CT scan showed a
well-deﬁned mass measuring 22×16×20 mm on the right side of the esophagus, along with 99mTc-MIBI
uptake in the lesion. Based on these ﬁndings, we diagnosed the patient with primary hyperparathyroidism.
Considering his general condition, we determined that parathyroidectomy was difﬁcult, and we started
treatment using cinacalcet. A temporary therapeutic effect was observed, but the turning point was
occurrence of hypercalcemic crisis with aspiration pneumonia. After recovery of his general condition and
improvement of blood data by multidisciplinary therapy, we performed parathyroidectomy.
Histopathological examination showed that the tumor was a parathyroid adenoma. He is free of reccurence
at one year postoperatively. In addition, surgery for spondylolisthesis was performed, and he started to walk
independently.
(Hinyokika Kiyo 62 : 633-637, 2016 DOI : 10.14989/ActaUrolJap_62_12_633)















患 者 : 77歳，男性
主 訴 : 右尿管結石の精査
既往歴 : 高血圧症，腰椎すべり症
家族歴 : 特記すべきことなし
現病歴 : 第 4腰椎すべり症の精査中，腹部 CT で右
尿管結石を指摘され当科紹介となった．
現 症 : 身長 163 cm，体重 41 kg，BMI 15.7 kg/m2
とるい痩を認め，performance status 4 と全身状態不良
であった．体温 37.1°C，脈拍 69/min，血圧 116/66
mmHg．背部叩打痛を認めなかった．
血液検査 : WBC 6, 400/mm3，Hb 7. 1 g/dl，Plt
24.1×104/μ l，TP 6.0 g/dl，Alb 3.2 g/dl，CRP 0.4
mg/dl，BUN 18.2 mg/dl，Cr 1.3 mg/dl，UA 2.6 mg/
dl，Na 138 mEq/l，K 3. 4 mEq/l，Ca 11. 8 mg/dl，P
2.6 mg/dl，補正Ca 12.6 mg/dl，intact PTH 555 pg/ml
（基準値 10∼65 pg/ml）
尿検査 : pH 5. 5，RBC 100/HPF，WBC 10∼19/
HPF．シュウ酸カルシウム結晶を認めた．
蓄尿検査 : Ca 0.14 g/day（基準値 0.10∼0.30 g/
day），P 0.69 g/day（基準値 0.50∼0.10 g/day），Mg
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Fig. 1. A computed tomography scan shows a right
ureteral stone (arrow) and highly calciﬁed





Fig. 2. a : A computed tomography scan shows a
well-deﬁned mass on the right side of the
esophagus. The mass shows enhancement
with contrast medium (arrow). b : 99mTc-
MIBI uptake in the lesion is shown on the
computed tomography scan (arrow head).
0.07 g/day（基 準 値 0.00∼0.10 g/day），シュ ウ 酸
17.6 mg/day（基準値 0.3∼41.5 mg/day），クエン酸
139 mg/l（基準値 138∼1,010 mg/l），尿酸 0.13 g/day
（基準値 0.40∼1.20 g/day）．蓄尿検査の前に高 Ca 血
症の治療としてゾレドロン酸が投与されており，尿中
Ca は正常値を示した．


























熱，血液検査では WBC 22,100/mm3，CRP 9.23 mg/
dl と高値を認めた．熱源精査の結果，誤嚥生肺炎と
診断した．その後，意識障害を来たした．血液生化学
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Fig. 3. Treatment progress and postoperative course.
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Fig. 5. a : HE staining × 100. Histopathological
examination shows solid proliferation of
chief cells, forming glandular cavities. b :
HE staining ×400. Nuclear division and
atypical cells are not observed.
















































正常上限から 1 mg/dl 以上の血清 Ca，○2 クレアチニ














0.2 mg/dl から本薬剤投与 4週後に 10.3±0.2 mg/dl
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